A phase I dose-escalation study of carfilzomib in patients with previously-treated systemic light-chain (AL) amyloidosis Meeting Abstract
| Authors: | Cohen, A. D.; Scott, E. C.; Liedtke, M.; Kaufman, J. L.; Landau, H.; Vesole, D. H.; Gomes, C. L.; Gasparetto, C.; Lentzsch, S.; Rosenzweig, M.; Sanchorawala, V.; Smith, D. D.; Comenzo, R. L.; Durie, B. G. M. |
| Abstract Title: | A phase I dose-escalation study of carfilzomib in patients with previously-treated systemic light-chain (AL) amyloidosis |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349233808070 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.4741.4741 |
| Notes: | Meeting Abstract: 4741 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
